A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Mise à jour : Il y a 4 ans
Référence : NCT01470313

Femme et Homme

Extrait

This study is designed to evaluate the safety and tolerability of multiple intravenously administered doses of PD-0360324 in patients with cutaneous lupus erythematosus. Changes in disease activity will also be evaluated.


Critère d'inclusion

  • Cutaneous Lupus Erythematosus

Liens